Simulations Plus Increases Net Income 49 Percent | San Fernando Valley Business Journal
Drug modeling software company Simulations Plus Inc. beat analyst estimates for its second fiscal quarter, with net income increasing a whopping 49 percent. The Lancaster-based company, which makes a platform used by the pharmaceutical industry for drug research and development, reported an adjusted net income of $3.2 million (15 cents a share) for the quarter ended Feb. 28, compared to adjusted net income of $2.15 million (12 cents) for the same quarter a year ago. Revenue increased 27 percent...
Shawn Oconnor Amy Stulick Simulations Plus Inc Simulations Plus Increases Net Income Simulations Plus Zacks Consensus
Source: sfvbj.com